NEU neuren pharmaceuticals limited

Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-7

  1. 2,184 Posts.
    lightbulb Created with Sketch. 556
    If the FDA had concerns about elements of the data then they would typically call an Advisory Committee together to seek advice/clarification around those outstanding inquiries. It seems to me that it speaks to the thoroughness of Acadia's submission, but it most certainly was supported by the work done a couple of months ago with parent forums and the input of the various leading Rett organizations. I can only see this as a very good statement.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.76
Change
0.170(1.17%)
Mkt cap ! $1.837B
Open High Low Value Volume
$14.36 $14.86 $14.25 $3.707M 254.0K

Buyers (Bids)

No. Vol. Price($)
1 2500 $14.70
 

Sellers (Offers)

Price($) Vol. No.
$14.80 1000 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.